Show simple item record

dc.contributor.authorO'Leary, MF
dc.contributor.authorWallace, GR
dc.contributor.authorBennett, AJ
dc.contributor.authorTsintzas, K
dc.contributor.authorJones, SW
dc.date.accessioned2019-03-06T09:39:58Z
dc.date.issued2017-10-11
dc.description.abstractStudies in murine cell lines and in mouse models suggest that IL-15 promotes myogenesis and may protect against the inflammation-mediated skeletal muscle atrophy which occurs in sarcopenia and cachexia. The effects of IL-15 on human skeletal muscle growth and development remain largely uncharacterised. Myogenic cultures were isolated from the skeletal muscle of young and elderly subjects. Myoblasts were differentiated for 8 d, with or without the addition of recombinant cytokines (rIL-15, rTNFα) and an IL-15 receptor neutralising antibody. Although myotubes were 19% thinner in cultures derived from elderly subjects, rIL-15 increased the thickness of myotubes (MTT) from both age groups to a similar extent. Neutralisation of the high-affinity IL-15 receptor binding subunit, IL-15rα in elderly myotubes confirmed that autocrine concentrations of IL-15 also support myogenesis. Co-incubation of differentiating myoblasts with rIL-15 and rTNFα, limited the reduction in MTT and nuclear fusion index (NFI) associated with rTNFα stimulation alone. IL-15rα neutralisation and rTNFα decreased MTT and NFI further. This, coupled with our observation that myotubes secrete IL-15 in response to TNFα stimulation supports the notion that IL-15 serves to mitigate inflammatory skeletal muscle loss. IL-15 may be an effective therapeutic target for the attenuation of inflammation-mediated skeletal muscle atrophy.en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.identifier.citationVol. 7, 12997en_GB
dc.identifier.doi10.1038/s41598-017-13479-w
dc.identifier.urihttp://hdl.handle.net/10871/36307
dc.language.isoenen_GB
dc.publisherNature Researchen_GB
dc.rights© The Author(s) 2017. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.en_GB
dc.subjectageingen_GB
dc.subjectmuscle stem cellsen_GB
dc.titleIL-15 promotes human myogenesis and mitigates the detrimental effects of TNF alpha on myotube developmenten_GB
dc.typeArticleen_GB
dc.date.available2019-03-06T09:39:58Z
dc.identifier.issn2045-2322
exeter.article-numberARTN 12997en_GB
dc.descriptionThis is the final version. Available from Nature Research via the DOI in this record.en_GB
dc.identifier.journalScientific Reportsen_GB
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/.en_GB
dcterms.dateAccepted2017-09-26
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2017-09-26
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-03-06T09:36:50Z
refterms.versionFCDVoR
refterms.dateFOA2019-03-06T09:40:00Z
refterms.panelCen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2017. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © The Author(s) 2017. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.